back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-01 17:28 Tx date 2024-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+647 vol |
169,906 | |
| Filed 2024-01-02 17:14 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,873
+857 vol $8.02 each |
169,259 | |
| Filed 2023-10-03 11:38 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,871
+836 vol $8.22 each |
168,402 | |
| Filed 2023-07-04 16:56 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,872
+859 vol $8.00 each |
167,566 | |
| Filed 2023-05-23 13:00 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
166,707 | |
| Filed 2023-04-05 12:42 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,868
+848 vol $8.10 each |
137,502 | |
| Filed 2023-01-04 17:07 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,870
+1,094 vol $6.28 each |
136,654 | |
| Filed 2022-10-04 16:41 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,869
+997 vol $6.89 each |
135,560 | |
| Filed 2022-07-06 15:06 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,871
+822 vol $8.36 each |
134,563 | |
| Filed 2022-06-29 13:11 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
133,741 | |
| Filed 2022-04-05 12:02 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,855
+300 vol $22.85 each |
99,354 | |
| Filed 2022-01-04 13:00 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+249 vol |
99,054 | |
| Filed 2021-10-04 18:26 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,851
+246 vol $27.85 each |
98,805 | |
| Filed 2021-07-05 11:29 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,860
+234 vol $29.32 each |
98,559 | |
| Filed 2021-05-28 16:54 Tx date 2021-05-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-350,811.045
-11,037 vol $31.79 each |
0 | |
| Filed 2021-05-03 19:59 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
98,325 | |
| Filed 2021-04-30 17:51 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$344,906
+11,037 vol $31.25 each |
11,037 | |
| Filed 2021-04-30 17:49 Tx date 2016-06-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-30 17:49 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,037 vol |
90,680 | |
| Filed 2021-04-05 13:13 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,855
+216 vol $31.74 each |
101,717 | |
| Filed 2021-01-07 12:07 Tx date 2020-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,864
+330 vol $20.80 each |
101,501 | |
| Filed 2020-10-05 12:58 Tx date 2020-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,868
+442 vol $15.54 each |
101,171 | |
| Filed 2020-07-03 11:41 Tx date 2020-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,858
+375 vol $18.29 each |
100,729 | |
| Filed 2020-05-04 11:09 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
100,354 | |
| Filed 2020-04-02 17:47 Tx date 2020-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,866
+443 vol $15.50 each |
89,317 | |
| Filed 2020-01-03 12:15 Tx date 2019-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,864
+1,065 vol $29.92 each |
88,874 | |
| Filed 2019-10-04 17:26 Tx date 2019-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,857
+1,458 vol $21.85 each |
87,809 | |
| Filed 2019-07-05 16:16 Tx date 2019-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,852
+1,263 vol $25.22 each |
86,351 | |
| Filed 2019-05-06 11:45 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
85,088 | |
| Filed 2019-04-12 10:18 Tx date 2019-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,290 vol |
74,455 | |
| Filed 2019-01-07 Tx date 2018-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,694
+1,716 vol $18.47 each |
73,165 | |
| Filed 2018-10-03 Tx date 2018-09-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,217 vol |
71,449 | |
| Filed 2018-07-06 Tx date 2018-06-29 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,234
+1,344 vol $23.24 each |
70,232 | |
| Filed 2018-05-10 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+13,881 vol |
68,888 | |
| Filed 2018-05-10 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
||
| Filed 2018-05-04 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
69,292 | |
| Filed 2018-04-06 Tx date 2018-03-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,235
+1,962 vol $15.92 each |
55,007 | |
| Filed 2018-01-03 Tx date 2017-12-29 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,503 vol |
53,045 | |
| Filed 2017-10-04 Tx date 2017-09-29 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,239
+2,180 vol $14.33 each |
51,542 | |
| Filed 2017-07-06 Tx date 2017-06-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,243
+1,806 vol $17.30 each |
49,362 | |
| Filed 2017-05-08 Tx date 2017-05-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+25,406 vol |
47,556 | |
| Filed 2017-04-10 Tx date 2017-03-31 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,133
+2,460 vol $11.03 each |
22,150 | |
| Filed 2017-01-06 Tx date 2016-12-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$24,988
+1,721 vol $14.52 each |
19,690 | |
| Filed 2016-10-06 Tx date 2016-09-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,018 vol |
17,969 | |
| Filed 2016-08-11 Tx date 2016-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-11 Tx date 2016-06-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$374,996
+16,726 vol $22.42 each |
16,726 | |
| Filed 2016-08-11 Tx date 2016-06-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$4,531
+225 vol $20.14 each |
16,951 |